Effective Treatment of Pterygium

Understanding when and how to best remove pterygia is vital for optimizing surgical outcomes and preventing disease recurrence.

By: Richard Najac, MD

Ophthalmology Management November 1, 2025 Vol 29, Issue November/December 2025 Page(s): 18-19

Clinical Report: Effective Treatment of Pterygium

Overview

Revise to specify the benefits of cryopreserved amniotic membranes in surgical management.

Background

Pterygium is a fibrovascular growth that can lead to visual impairment and discomfort, particularly in populations with high UV exposure. Understanding the appropriate timing for surgical intervention is crucial to prevent complications such as corneal scarring and astigmatism. Effective management strategies are essential for improving patient quality of life and surgical success.

Data Highlights

No numerical data provided in the source material.

Key Findings

Pterygium removal is ideally performed after it crosses the limbus but before it affects the pupillary axis.
Preoperative assessment for ocular comorbidities can reduce inflammation and improve surgical outcomes.
Cryopreserved amniotic membranes (CAMs) are increasingly used in pterygium excision to decrease recurrence rates.
Conjunctival autografts remain the gold standard for reducing pterygium recurrence.
Patient education regarding postoperative expectations is vital for satisfaction and recovery.

Clinical Implications

Surgeons should carefully evaluate the timing of pterygium excision to balance the risks of recurrence and visual impairment. Incorporating CAMs into surgical practice may enhance outcomes and reduce complications. Effective patient counseling can improve postoperative experiences.

Conclusion

Timely intervention and the use of advanced surgical techniques are key to optimizing pterygium management. Continued research and clinical practice refinement will further enhance patient care.

PentaVision

Ophthalmology Management